Form4insider filings, from the source

SEC Form 4 · accession 0000919574-15-005229

Lineage Cell Therapeutics, Inc. · LCTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Neal C Bradsher
Director · 10% Owner
Period of report
Jul 1, 2015
Accepted (ET)
Jul 6, 2015 · 5:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876343

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
OPTION TO PURCHASE COMMON SHARESF5,F1,F3$3.57Jul 1, 2015A20,000A—Jun 30, 2020COMMON SHARES20,00020,000D
OPTION TO PURCHASE COMMON SHARESF1,F4$3.11holding————Jun 30, 2019COMMON SHARES20,00020,000D
OPTION TO PURCHASE COMMON SHARESF1,F4$4.13holding————Jun 30, 2018COMMON SHARES20,00020,000D
OPTION TO PURCHASE COMMON SHARESF1,F4$4.60holding————Jun 30, 2017COMMON SHARES20,00020,000D
OPTION TO PURCHASE COMMON SHARESF1,F4$5.13holding————Jun 30, 2016COMMON SHARES20,00020,000D
OPTION TO PURCHASE COMMON SHARESF1,F4$5.45holding————Aug 9, 2015COMMON SHARES20,00020,000D
OPTION TO PURCHASE COMMON SHARESF2,F4$5.00holding————Jun 4, 2018COMMON SHARES50,00050,000I

Explanation of responses